Drug
Psilocybin 25mg
Psilocybin 25mg is a pharmaceutical drug with 4 clinical trials. Currently 3 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
3(75%)
Phase Distribution
Ph phase_1
1
25%
Ph phase_2
3
75%
Phase Distribution
1
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
3(75.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
4
all time
Status Distribution
Active(4)
Detailed Status
Recruiting2
Not yet recruiting1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
3
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 11 (25.0%)
Phase 23 (75.0%)
Trials by Status
not_yet_recruiting125%
active_not_recruiting125%
recruiting250%
Recent Activity
3 active trials
Showing 4 of 4
not_yet_recruitingphase_2
Understanding Music and Mindfulness Preferences in Psilocybin-Assisted Psychotherapy
NCT07373535
recruitingphase_2
State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma
NCT06888128
active_not_recruitingphase_2
Psilocybin for Treatment-Resistant Depression
NCT06230757
recruitingphase_1
Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based Programs
NCT06815653
Clinical Trials (4)
Showing 4 of 4 trials
NCT07373535Phase 2
Understanding Music and Mindfulness Preferences in Psilocybin-Assisted Psychotherapy
NCT06888128Phase 2
State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma
NCT06230757Phase 2
Psilocybin for Treatment-Resistant Depression
NCT06815653Phase 1
Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based Programs
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4